163 related articles for article (PubMed ID: 23209830)
1. A DKP cyclo(L-Phe-L-Phe) found in chicken essence is a dual inhibitor of the serotonin transporter and acetylcholinesterase.
Tsuruoka N; Beppu Y; Koda H; Doe N; Watanabe H; Abe K
PLoS One; 2012; 7(11):e50824. PubMed ID: 23209830
[TBL] [Abstract][Full Text] [Related]
2. Development of an efficient therapeutic agent for Alzheimer's disease: design and synthesis of dual inhibitors of acetylcholinesterase and serotonin transporter.
Toda N; Kaneko T; Kogen H
Chem Pharm Bull (Tokyo); 2010 Mar; 58(3):273-87. PubMed ID: 20190429
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of RS-1259, an orally active dual inhibitor of acetylcholinesterase and serotonin transporter, in rodents: possible treatment of Alzheimer's disease.
Abe Y; Aoyagi A; Hara T; Abe K; Yamazaki R; Kumagae Y; Naruto S; Koyama K; Marumoto S; Tago K; Toda N; Takami K; Yamada N; Ori M; Kogen H; Kaneko T
J Pharmacol Sci; 2003 Sep; 93(1):95-105. PubMed ID: 14501158
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, in vitro evaluation and molecular docking of a new class of indolylpropyl benzamidopiperazines as dual AChE and SERT ligands for Alzheimer's disease.
Rodríguez-Lavado J; Gallardo-Garrido C; Mallea M; Bustos V; Osorio R; Hödar-Salazar M; Chung H; Araya-Maturana R; Lorca M; Pessoa-Mahana CD; Mella-Raipán J; Saitz C; Jaque P; Reyes-Parada M; Iturriaga-Vásquez P; Pessoa-Mahana H
Eur J Med Chem; 2020 Jul; 198():112368. PubMed ID: 32388114
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological and behavioral characterization of D-473, an orally active triple reuptake inhibitor targeting dopamine, serotonin and norepinephrine transporters.
Dutta AK; Santra S; Sharma H; Voshavar C; Xu L; Mabrouk O; Antonio T; Reith ME
PLoS One; 2014; 9(11):e113420. PubMed ID: 25427177
[TBL] [Abstract][Full Text] [Related]
6. Purification, structural elucidation and bioactivity of tryptophan containing diketopiperazines, from Comamonas testosteroni associated with a rhabditid entomopathogenic nematode against major human-pathogenic bacteria.
Kumar SN; Mohandas C; Nambisan B
Peptides; 2014 Mar; 53():48-58. PubMed ID: 24120705
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of dual inhibitors of acetylcholinesterase and serotonin transporter targeting potential agents for Alzheimer's disease.
Kogen H; Toda N; Tago K; Marumoto S; Takami K; Ori M; Yamada N; Koyama K; Naruto S; Abe K; Yamazaki R; Hara T; Aoyagi A; Abe Y; Kaneko T
Org Lett; 2002 Oct; 4(20):3359-62. PubMed ID: 12323018
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and structure-activity relationships of dual inhibitors of acetylcholinesterase and serotonin transporter as potential agents for Alzheimer's disease.
Toda N; Tago K; Marumoto S; Takami K; Ori M; Yamada N; Koyama K; Naruto S; Abe K; Yamazaki R; Hara T; Aoyagi A; Abe Y; Kaneko T; Kogen H
Bioorg Med Chem; 2003 May; 11(9):1935-55. PubMed ID: 12670645
[TBL] [Abstract][Full Text] [Related]
9. Unambiguous Stereochemical Assignment of Cyclo(Phe-Pro), Cyclo(Leu-Pro), and Cyclo(Val-Pro) by Electronic Circular Dichroic Spectroscopy.
Domzalski A; Margent L; Vigo V; Dewan F; Pilarsetty NVK; Xu Y; Kawamura A
Molecules; 2021 Oct; 26(19):. PubMed ID: 34641525
[TBL] [Abstract][Full Text] [Related]
10. 5-Methoxy-N,N-diisopropyltryptamine (Foxy), a selective and high affinity inhibitor of serotonin transporter.
Sogawa C; Sogawa N; Tagawa J; Fujino A; Ohyama K; Asanuma M; Funada M; Kitayama S
Toxicol Lett; 2007 Apr; 170(1):75-82. PubMed ID: 17382495
[TBL] [Abstract][Full Text] [Related]
11. [(3)H] citalopram binding to serotonin transporter sites in minnow brains.
Gould GG; Brooks BW; Frazer A
Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):203-10. PubMed ID: 17697042
[TBL] [Abstract][Full Text] [Related]
12. Vascular reactivity, 5-HT uptake, and blood pressure in the serotonin transporter knockout rat.
Linder AE; Diaz J; Ni W; Szasz T; Burnett R; Watts SW
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1745-52. PubMed ID: 18263707
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of diketopiperazines from Moslae Herba against influenza A virus-induced pulmonary inflammation via inhibition of viral replication and platelets aggregation.
Zhang HH; Yu WY; Li L; Wu F; Chen Q; Yang Y; Yu CH
J Ethnopharmacol; 2018 Apr; 215():156-166. PubMed ID: 29309861
[TBL] [Abstract][Full Text] [Related]
14. Further studies on conformationally constrained tricyclic tropane analogues and their uptake inhibition at monoamine transporter sites: synthesis of (Z)-9-(substituted arylmethylene)-7-azatricyclo[4.3.1.0(3,7)]decanes as a novel class of serotonin transporter inhibitors.
Zhang A; Zhou G; Hoepping A; Mukhopadhyaya J; Johnson KM; Zhang M; Kozikowski AP
J Med Chem; 2002 Apr; 45(9):1930-41. PubMed ID: 11960503
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a cyclopentylamine as an orally active dual NK1 receptor antagonist-serotonin reuptake transporter inhibitor.
Wu YJ; He H; Gao Q; Wu D; Bertekap R; Westphal RS; Lelas S; Newton A; Wallace T; Taber M; Davis C; Macor JE; Bronson J
Bioorg Med Chem Lett; 2014 Mar; 24(6):1611-4. PubMed ID: 24507922
[TBL] [Abstract][Full Text] [Related]
16. GABA, glutamate, dopamine and serotonin transporters expression on memory formation and amnesia.
Tellez R; Gómez-Víquez L; Meneses A
Neurobiol Learn Mem; 2012 Feb; 97(2):189-201. PubMed ID: 22183017
[TBL] [Abstract][Full Text] [Related]
17. Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs.
Zhao Z; Zhang HT; Bootzin E; Millan MJ; O'Donnell JM
Neuropsychopharmacology; 2009 May; 34(6):1467-81. PubMed ID: 18923402
[TBL] [Abstract][Full Text] [Related]
18. Chiral gas chromatography of 2,5-diketopiperazines following a ring-opening derivatization method for complete isomeric separation.
Mimura K; Okada R; Nishida T
J Chromatogr A; 2018 Sep; 1566():118-123. PubMed ID: 29954611
[TBL] [Abstract][Full Text] [Related]
19. A study in male and female 5-HT transporter knockout rats: an animal model for anxiety and depression disorders.
Olivier JD; Van Der Hart MG; Van Swelm RP; Dederen PJ; Homberg JR; Cremers T; Deen PM; Cuppen E; Cools AR; Ellenbroek BA
Neuroscience; 2008 Mar; 152(3):573-84. PubMed ID: 18295409
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of JNJ-28583867, a histamine H(3) receptor antagonist and serotonin reuptake inhibitor.
Barbier AJ; Aluisio L; Lord B; Qu Y; Wilson SJ; Boggs JD; Bonaventure P; Miller K; Fraser I; Dvorak L; Pudiak C; Dugovic C; Shelton J; Mazur C; Letavic MA; Carruthers NI; Lovenberg TW
Eur J Pharmacol; 2007 Dec; 576(1-3):43-54. PubMed ID: 17765221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]